论文部分内容阅读
目的观察曲唑酮联合双歧杆菌四联活菌片对肠易激综合征患者的临床疗效。方法 85例肠易激综合征患者随机分成二组,对照组常规用药,实验组加用曲唑酮联合活菌制剂治疗,4周后观察疗效,评估患者症状改善程度及心理状况。结果患者症状改善程度及心理状况较对照组明显改善,P<0.05,有统计学意义。结论曲唑酮联合活菌制剂治疗肠易激综合征疗效肯定,适用于临床。
Objective To observe the clinical efficacy of trazodone combined with bifidobacterium quadriceps in the treatment of patients with irritable bowel syndrome. Methods 85 cases of irritable bowel syndrome patients were randomly divided into two groups. The control group was given conventional drugs. The experimental group was treated with trazodone combined with viable bacteria. The curative effect was observed after 4 weeks. The degree of improvement of symptoms and psychological status were evaluated. Results The degree of symptom improvement and psychological status of patients were significantly improved compared with the control group, P <0.05, with statistical significance. Conclusion Trazodone combined with viable preparations for the treatment of irritable bowel syndrome efficacy is valid for clinical.